1 minute read
The Supreme Court was addressing a petition from the Indian Medical Association (IMA), which accused Ramdev of conducting a smear campaign against the vaccination effort and contemporary medical practices.
In November 2023, the Supreme Court objected to Patanjali Ayurved making ‘false’ claims to cure diseases in its advertisements and threatened to impose costs on the company for resorting to such practices.
“All false and misleading advertisements of Patanjali Ayurved have to stop immediately. This court will take such infractions very seriously, and will consider imposing costs of up to Rs 1 crore on every product regarding which a false claim is made that it can cure a particular disease,” the bench had said.
Also Read- Pasighat Police arrested two accused of a murder case committed in Guwahati
However, given that Patanjali continued to publish such misleading and prima facie flouted this undertaking, the Court issued Contempt notice to Patanjali Ayurved and Acharya Balakrishna (Managing Director of Patanjali).
The Court also restrained Patanjali Ayurved from advertising or branding its products which are meant to address the diseases/disorders specified in the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954 in the meantime. It further cautioned Patanjali Ayurved from making any statement adverse to any system of medicine.